Our Focus

IMARC Research was founded in 1999 and has emerged as a well-respected, high-quality niche contract research organization serving the medical device and biotechnology industries. Our market focus allows us to provide strong expertise and guidance in an ever-changing regulatory landscape. We serve to protect research participants by providing independent, third-party oversight of our client’s critical clinical studies.

IMARC assists the clinical research community in the pursuit of FDA and worldwide approvals. Our effectiveness is built on preparing, educating, complementing and guiding site teams from Day 1. We control the complex management of trials through cost-effective monitoring, auditing and training services. This results in the support, proof and assurance they seek to overcome chaos caused by complexity, while achieving compliance through consistency.

Started by a former research coordinator, IMARC is more than a typical vendor. We pride ourselves on being able to understand issues at both the site level and sponsor level, and to effectively work through those issues throughout the course of the trial.

Some of the benefits of IMARC’s involvement include:

• Strong track record with FDA
• IMARC's core services address top reasons for FDA failures
• Provide independent, third-party oversight to your critical clinical studies
• IMARC's company culture

IMARC can fully integrate into the study teams of sponsors or CROs while still providing the independence and objectivity that comes from being a separate company.

For additional information on IMARC Research, please contact John E. Lehmann at 440.801.1540.